EFFICACY AND SAFETY OF INCOBOTULINUMTOXINA FOR THE TREATMENT OF SIALORRHEA: RESULTS OF THE MAIN PHASE OF A PHASE 3 STUDY

被引：0
|
作者：
Jost, Wolfgang H. [1 ]
Michel, Olaf [2 ]
Oehlwein, Christian [3 ]
Slawek, Jaroslaw [4 ,5 ]
Bogucki, Andrzej [6 ]
Ochudlo, Stanislaw [7 ,8 ]
Banach, Marta [9 ]
Pagan, Fernando [10 ]
Flatau-Baque, Birgit [11 ]
Csikos, Janos [11 ]
Blitzer, Andrew [12 ]
机构：
[1] Parkinson Klin Ortenau, Wolfach, Germany
[2] Vrije Univ Brussel, Univ Hosp Brussels, Dept Otorhinolcuyngol, Brussels, Belgium
[3] Neurol Outpatient Clin Parkinson Dis & Deep Brain, Gera, Germany
[4] Med Univ Gdansk, Dept Neurol Psychiat Nursing, Gdansk, Poland
[5] St Adalbert Hosp, Dept Neurol, Gdansk, Poland
[6] Med Univ Lodi, Dept Extrapyramidal Dis, Lodi, Italy
[7] Med Univ Silesia, Dept Neurol, Katowice, Poland
[8] Med Univ Silesia, Stroke Unit, Katowice, Poland
[9] Jagiellonian Univ, Dept Neurol, Coll Med, Krakow, Poland
[10] Georgetown Univ, Dept Neurol, Washington, DC USA
[11] Merz Pharmaceut GmbH, Frankfurt, Germany
[12] Columbia Univ Coll Phys & Surg, Icahn Sch Med Mt Sinai, Dept Otolaryngol Head & Neck Surg, Dept Neurol,New York Ctr Voice & Swallowing Disor, New York, NY USA
来源：
TOXICON | 2018年 / 156卷
关键词：
Botulinum toxin; IncobotulinumtoxinA; Parkinson's disease; Sialorrhea; SIAXI; Stroke;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
116
引用
下载
收藏
页码：S53 / S53
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 study
    J F San-Miguel
    P G Richardson
    P Sonneveld
    M W Schuster
    D Irwin
    E A Stadtmauer
    T Facon
    J-L Harousseau
    D Ben-Yehuda
    S Lonial
    H Goldschmidt
    D Reece
    J Bladé
    M Boccadoro
    J D Cavenagh
    R Neuwirth
    A L Boral
    D-L Esseltine
    K C Anderson
    Leukemia, 2008, 22 : 842 - 849
  • [32] Efficacy and Safety of Tocilizumab for the Treatment of Systemic Sclerosis: Results from a Phase 3 Randomized Controlled Trial
    Khanna, Dinesh
    Lin, Celia J. F.
    Kuwana, Masataka
    Allanore, Yannick
    Batalov, Anastas
    Butrimiene, Irena
    Carreira, Patricia
    Cerinic, Marco Matucci
    Distler, Oliver
    Kaliterna, Dusanka Martinovic
    Mihai, Carina
    Mogensen, Mette
    Olesinska, Marzena
    Pope, Janet E.
    Riemekasten, Gabriela
    Rodriguez-Reyna, Tatiana S.
    Jose Santos, Maria
    van Laar, Jacob
    Spotswood, Helen
    Siegel, Jeffrey
    Jahreis, Angelika
    Furst, Daniel E.
    Denton, Christopher P.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [33] Treatment of diabetic nephropathy with sulodexide: Final phase II safety and efficacy results
    Lewis, Edmund J.
    Lewis, Julia
    Blumenthal, Samuel S.
    Wiegmann, Thomas
    Huniscker, Lawrence
    Raz, Itamar
    DIABETES, 2007, 56 : A152 - A153
  • [34] THE EFFICACY AND SAFETY OF A 1.62% TESTOSTERONE GEL FOR THE TREATMENT OF HYPOGONADAL MEN: PRIMARY EFFICACY RESULTS FROM A PHASE III STUDY
    Kaufman, J. M.
    Brennan, J. J.
    Garwin, J. L.
    Miller, M. G.
    Fitzpatrick, S.
    McWhirter, C.
    JOURNAL OF SEXUAL MEDICINE, 2011, 8 : 8 - 8
  • [35] THE EFFICACY AND SAFETY OF A 1.62% TESTOSTERONE GEL FOR THE TREATMENT OF HYPOGONADAL MEN: PRIMARY EFFICACY RESULTS FROM A PHASE III STUDY
    Kaufman, Joel M.
    Brennan, John J.
    Garwin, Jeffrey L.
    Miller, Michael G.
    Fitzpatrick, Sherahe
    McWhirter, Cecilia
    JOURNAL OF ANDROLOGY, 2011, : 52 - 52
  • [36] The Efficacy and Safety of a 1.62% Testosterone Gel for the Treatment of Hypogonadal Men: Efficacy Results from a Phase III Study.
    Kaufman, Joel M.
    Brennan, John J.
    Garwin, Jeffrey L.
    Miller, Michael G.
    Fitzpatrick, Sherahe
    McWhirter, Cecilia
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [37] EFFICACY AND SAFETY OF ANAKINRA IN THE TREATMENT OF RECURRENT GOUT FLARES: RESULTS FROM THE EXTENSION PHASE OF THE ANAGO STUDY
    Saag, K.
    Khanna, P.
    Keenan, R.
    Ohlman, S.
    Sparve, E.
    Lindqvist, D.
    Akerblad, A. C.
    Wiken, M.
    So, A.
    Pillinger, M. H.
    Terkeltaub, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 452 - 453
  • [38] DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Efficacy Results From SAKURA 3, a Large, Open-Label, Phase 3 Safety Study
    Fabi, Sabrina G.
    Cohen, Joel L.
    Green, Lawrence J.
    Dhawan, Sunil
    Kontis, Theda C.
    Baumann, Leslie
    Gross, Todd M.
    Gallagher, Conor J.
    Brown, Jessica
    Rubio, Roman G.
    DERMATOLOGIC SURGERY, 2021, 47 (01) : 48 - 54
  • [39] EFFICACY AND SAFETY OF MIRIKIZUMAB IN PATIENTS WITH ULCERATIVE COLITIS: PHASE 3 LUCENT-1 STUDY RESULTS
    D'Haens, Geert
    Kobayashi, Taku
    Morris, Nathan
    Lissoos, Trevor
    Hoover, Amy
    Li, Xingyuan
    Arora, Vipin
    Milch, Catherine
    Sandborn, William J.
    Sands, Bruce E.
    Irving, Peter
    GUT, 2022, 71 : A16 - A17
  • [40] Efficacy and safety of Cinryze for the prevention of hereditary angioedema attacks in children: interim results of a Phase 3 study
    Aygoren-Pursun, E.
    Moldovan, D.
    Christensen, J.
    van, Leerberghe A.
    Wu, Y.
    Schranz, J.
    Martinez-Saguer, I
    Soteres, D.
    ALLERGY, 2016, 71 : 296 - 296
12345